Quality, Compliance & Regulatory - software & AI news

Daily news on software, AI, and companies shaping quality, compliance & regulatory.

Showing 124 results
An open research notebook with a pen in a dimly lit office setting.

May 30, 2026

Simplification, standardisation & AI-enabled industry: Veeva R&D and Quality Summit 2026

The Veeva R&D and Quality Summit 2026 in Copenhagen focused on advancing the life sciences industry through standardization and AI integration.This year's summit, held on May 28-29, emphasized the vision of creating a unified industry cloud aimed at improving patient outcomes. Veeva, a leader in providing cloud solutions for life sciences, serves a diverse clientele, including major pharmaceutical firms and emerging biotech companies. Senior VP Rik Van Mol highlighted the importance of collabora
Flat design of a cloud and gear representing Veeva's cloud platform and quality management tools.

May 28, 2026

Why Veeva Systems (VEEV) Stock Is Up Today

Veeva Systems’ stock saw a notable increase of 3.8% following the announcement of Kindeva's adoption of its Veeva Quality Cloud platform, aimed at modernizing manufacturing operations.Kindeva, a global contract development and manufacturing organization, plans to unify its global sites on Veeva's cloud platform, leveraging its quality management and training tools. This strategic move not only enhances Kindeva’s operational efficiency but also signifies a substantial win for Veeva, underscoring
A medical device prototype showcased at a tech expo, surrounded by blurred attendees.

May 28, 2026

Tata Elxsi Launches AnaTel™, an AI-Native Software Development Platform for Healthcare and Med-Tech Powered by OpenAna

Tata Elxsi has unveiled AnaTel™, an innovative AI-native software development platform tailored for the healthcare and medical technology sectors, in collaboration with OpenAna.Launched at DeviceTalks Boston 2026, AnaTel™ aims to tackle increasing operational challenges faced by medtech software teams, particularly in light of stringent regulatory requirements for AI-enabled device software. With the FDA and European guidelines demanding rigorous lifecycle documentation and validation, AnaTel™ i
Abstract representation of an AI agent in healthcare

May 28, 2026

Tata Elxsi launches AnaTel AI platform for healthcare

Tata Elxsi has introduced AnaTel, a cutting-edge AI development platform tailored for the healthcare sector, aiming to significantly expedite software development timelines.This platform, co-created with OpenAna, is designed to meet increasing regulatory demands by integrating autonomous AI agents into engineering workflows. Unveiled at DeviceTalks Boston 2026, AnaTel can potentially cut development cycles by up to 60%, addressing the operational hurdles that medtech software teams face, particu
A medical notebook and pen on a wooden table in a clinical workspace

May 27, 2026

Tata Elxsi launches AnaTel, an AI native software development platform

Tata Elxsi has introduced AnaTel, a pioneering AI-native software development platform tailored for healthcare and medical technology sectors, in collaboration with OpenAna. This launch occurred at DeviceTalks Boston 2026, showcasing advancements in AI-driven MedTech engineering and compliance.The healthcare and medtech industries are currently grappling with increasing regulatory demands, particularly concerning AI-enabled device software. Upcoming guidance from the FDA and Europe's MDCG emphas
A heart model in a clinical setting with a medical chart in the background.

May 27, 2026

Cardiac AI Diagnostics Clears China Regulatory Gate Via Lishman Global As Edison Award, Northern California Deployment, And Indigenous Partnership Stack Validation

VentriPoint Diagnostics Ltd. is making significant strides in the cardiac AI diagnostics space, recently achieving multiple validation milestones that enhance its market positioning in China and beyond.In a notable development, VentriPoint's VMS+™ 4.0 system has been submitted for regulatory approval to China's National Medical Products Administration (NMPA) via its partner, Lishman Global. This submission benefits from the NMPA's "green channel," which expedites the approval process for innovat
Minimalist illustration of a medical device

May 27, 2026

Tata Elxsi Launches ViTel for AI-Driven Material Intelligence in MedTech

Tata Elxsi has unveiled ViTel™, an innovative AI-driven material intelligence solution tailored for the medical device sector, highlighting its commitment to enhancing MedTech engineering and compliance.Introduced at DeviceTalks Boston 2026, ViTel is a collaborative effort with Viridium AI, aimed at addressing the complexities faced by medical device manufacturers. These challenges include stringent compliance requirements, sourcing risks, and the management of fragmented data across various ent
A compliance document and pen on a wooden desk in a dimly lit office.

May 26, 2026

Beyond Digital: The Future of AI-Powered Life Sciences Compliance

The life sciences sector is undergoing a transformative shift towards AI-powered compliance, emphasizing efficiency while navigating regulatory challenges.The article discusses the increasing importance of artificial intelligence in enhancing compliance within the life sciences industry. As organizations evolve from basic digital systems to more intelligent operations, the integration of AI is seen as a strategic necessity. ValGenesis, a leader in digital validation, is organizing the ValConnect
A minimalist illustration of a pill bottle and a pill on a solid background.

May 26, 2026

LSPedia Secures Investment to Fuel AI-Driven Pharma Supply Chain

LSPedia has secured a significant investment aimed at enhancing its AI-driven solutions for pharmaceutical supply chains, marking a shift from mere compliance to a more predictive and automated model that addresses critical industry challenges.Recently, LSPedia, a prominent player in pharmaceutical supply chain software, received a strategic growth investment from Bregal Sagemount. This funding is intended to help LSPedia evolve its operations beyond regulatory compliance, focusing instead on cr
A clipboard with regulatory documents on a wooden desk in a clinical office

May 26, 2026

What’s changing in AI regulation for drug development

Recent regulatory developments are shifting the landscape for AI in drug development, as organizations pivot from experimentation to establishing robust AI systems that meet regulatory standards.On January 14, the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) released joint guiding principles aimed at defining good AI practices in drug development. These principles serve as a reference for integrating AI into regulated processes, emphasizing the need for risk-base
Cold storage unit with pharmaceutical products in a dimly lit warehouse

May 26, 2026

How Digital Strategies Transform Pharma Supply Chains in 2026

The pharmaceutical supply chain is evolving rapidly, driven by the need for agility and compliance amid increasing operational complexities. As margins tighten, companies must adopt digital strategies to enhance performance and mitigate risks associated with regulatory pressures and geopolitical challenges.The article outlines how pharmaceutical leaders are leveraging digital transformation to optimize supply chain efficiency. Emphasizing Eliyahu Goldratt’s Theory of Constraints (TOC), it highli
A petri dish with bacterial culture in a dim lab setting

May 22, 2026

Ennov: Strategic Growth Investment From Bregal Sagemount And Ardian To Expand AI-Driven Life Sciences Software Platform

Ennov, a key player in the life sciences software sector, has secured a strategic investment from Bregal Sagemount and Ardian to enhance its AI-driven solutions. This funding aims to accelerate the company's growth by expanding its product offerings and global market reach.Headquartered in Paris, Ennov specializes in regulatory, quality, and clinical software solutions, providing a comprehensive compliance platform for life sciences organizations. This platform streamlines various operational ar